Xeris Biopharma Holdings Inc (XERS)
EBITDA
$16.59M
TTM · Period ending: · USD
XERS EBITDA
Latest reported$16.59Mperiod ending
Latest reported$16.59Mperiod ending
XERS TTM EBITDA (-$26.39M → $16.59M)
TTM EBITDA
High-resolution chart · PNG
XERS ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| 16,589,000 | |
| 46,127,000 | |
| 35,027,000 | |
| 26,623,000 | |
| 7,393,000 | |
| -4,339,000 | |
| -13,994,000 | |
| -23,066,000 | |
| -17,237,000 | |
| -24,725,000 | |
| -23,735,000 | |
| -25,784,000 | |
| -38,571,000 | |
| -47,959,000 | |
| -68,091,000 | |
| -110,788,000 | |
| -119,566,000 | |
| -124,952,000 | |
| -113,666,000 | |
| -82,391,000 | |
| -71,792,000 | |
| -68,041,000 | |
| -79,123,000 | |
| -93,932,000 | |
| -109,633,000 | |
| -121,082,000 | |
| -117,797,000 | |
| -105,358,000 | |
| -90,393,000 | |
| -69,642,000 | |
| -57,215,000 | |
| -47,116,000 | |
| -40,611,000 | |
| -33,430,000 | |
| -26,388,000 |